<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">

 

2018 INVESTOR

PERCEPTION REPORT

 

DOWNLOAD THE REPORT

ABOUT The report

The 2nd Biotech and Money Investor perception survey has been designed to take the temperature of the investment landscape, helping life science companies to enhance their understanding of the investment community’s priorities and enabling investment professionals to benchmark their approaches and perceptions against those of peers. 

The report covers issues such as the impact of Brexit on investment decisions, expectations for M&A transactions in 2018, the most significant risks facing the European life sciences sector, as well as the geographical regions and therapeutic areas seen as providing the greatest investment opportunities. It also provides insight into how the effectiveness of management teams influences investment decisions, and what life science companies can do to improve their chances when pitching to investors.

DOWNLOAD THE REPORT

Final BMWC Thumbnails.png

TRends and truth in life sciences investment 

Biotech and Money Investor Perception Survey 2018